Was FSMA 204 Really Delayed to July 2028? What Every Other Article Gets Wrong

Short answer: no — not in the way most articles say. FDA published a delay document on 7 August 2025 (90 FR 38084; document number 2025-14967; docket FDA-2014-N-0053), but that document is a proposed rule and, as of 16 July 2026, it has never been finalized. The original compliance date of 20 January 2026 remains in the regulation as written and was never formally amended. The reason enforcement is not happening now, and the reason 20 July 2028 is the date everyone repeats, is a congressional appropriations act (P.L. 119-37) that prohibits FDA from spending money on enforcement — a different legal mechanism with different consequences.

I am an engineer, not a lawyer, and I sell checkweighers, combination metal-detection/checkweighing systems and X-ray inspection machines for a living. So you should reasonably ask why I am writing about a recordkeeping rule. The answer is that the same confusion that produces "FSMA 204 was delayed to 2028" also produces "you need an FSMA 204 compliant checkweigher" — and one of those errors costs you a planning assumption, while the other costs you money on equipment bought for the wrong reason. Both are worth clearing up.

The Timeline, Stated Precisely

Here is the sequence, with each step labelled by what kind of legal instrument it actually is. This matters, because a proposed rule, a final rule and an appropriations rider are three different things with three different levels of durability.

Step 1 — The rule as written

The Food Traceability Rule established a compliance date of 20 January 2026. That date is still in the current regulation. It has never been formally amended out. This is not a technicality invented for a blog post — it is FDA's own characterization, in FDA's own wording, in the full text of Federal Register document 2026-10603 published on 28 May 2026.

Step 2 — The proposed delay

On 7 August 2025, FDA published a document proposing to extend the compliance date (90 FR 38084; document 2025-14967; docket FDA-2014-N-0053). Read the header: it is a proposed rule. A proposed rule is a request for comment. It does not change the Code of Federal Regulations. It becomes binding only when FDA issues a final rule. As of 16 July 2026 — verified directly against the Federal Register — no final rule has issued. The proposal has been pending for over eleven months.

Step 3 — Where 20 July 2028 actually comes from

The date that has propagated across the industry does not come from FDA at all. It comes from a congressional appropriations act, P.L. 119-37. Mechanically, it operates as a prohibition on FDA spending appropriated funds to enforce the rule — not as an amendment to the rule. FDA's own characterization of this mechanism is well documented; the specific section reference within the public law is reported via a Congressional Research Service report (R48925) accessed through a mirror, because congress.gov returned a 403 and we could not read the primary text directly. So treat the section number as reported rather than verified, and have your counsel confirm it against the enrolled text before you put it in a board memo.

Step 4 — It is still moving

FSMA 204 is not settled. Flexibility around lot-level tracking has not been finalized, and Congress has directed FDA to communicate with industry on a quarterly basis. That is from the full text of Federal Register document 2026-10603, published 28 May 2026. Anyone telling you the file is closed until 2028 is telling you something the record does not support.

Why "Delayed" and "Unenforced" Are Not the Same Word

This is the whole point of the article, so let me be blunt about the practical difference.

If a compliance date has been formally moved by a final rule, the obligation itself has moved. There is a new date in the regulation, and everyone — FDA, courts, your customers, your auditors — reads the same new date.

If a compliance date is untouched but enforcement is defunded by an appropriations act, the obligation as written is still the obligation as written. What has changed is that one particular agency cannot spend appropriated money enforcing it during the period the act covers. Appropriations are periodic instruments by nature. And the enforcement posture of a federal agency is not the only force acting on you: your buyer's supplier agreement, a retailer's onboarding questionnaire, a third-party certification scheme, or a customer's own traceability program can all reference the rule regardless of what FDA's budget says.

So the honest planning statement is not "we have until July 2028." It is: "the compliance date in the regulation is unchanged; a proposed extension is pending and unfinalized; federal enforcement is currently blocked by an appropriations mechanism; and our contractual exposure is independent of all three." That sentence is longer, and it is the one that survives contact with your legal team.

Common Misconception vs. Fact

Misconception 1: "FDA delayed FSMA 204 to July 2028." Fact: FDA published a proposed rule to extend the date on 7 August 2025 and has not finalized it. The July 2028 date traces to a congressional appropriations act, not to FDA rulemaking.

Misconception 2: "The 20 January 2026 date is dead." Fact: it is still in the regulation as written and was never formally amended — that is FDA's own wording in the 28 May 2026 Federal Register document.

Misconception 3: "Nothing will change before 2028, so we can stop watching." Fact: lot-level tracking flexibility is unresolved and Congress has directed FDA to engage with industry quarterly. The file is open.

Misconception 4: "We need an FSMA 204 compliant checkweigher / metal detector / X-ray machine." Fact: FSMA 204 imposes zero requirements on equipment. It is a recordkeeping rule. There is no such thing as an FSMA 204 compliant machine, and any vendor — including us — claiming otherwise is making a claim that does not stand up.

Misconception 5: "FSMA covers net weight, so my checkweigher is an FSMA device." Fact: FSMA contains no net-content provisions at all. Net content sits in an entirely separate legal system — the Fair Packaging and Labeling Act, 21 CFR 101.7(q), and NIST Handbook 133. (Note for anyone chasing citations: the old 101.105 was renumbered to 101.7.) Mixing these two systems is one of the most common confusions I see in RFQs from overseas buyers, and it leads people to buy equipment to satisfy a rule that never mentioned equipment.

Then Which Regulation Actually Touches My Inspection Line?

For human food in the United States, the regulatory hook that actually reaches your metal detector, X-ray system or checkweigher is 21 CFR Part 117 — Preventive Controls for Human Food. And here is the part vendors skip: Part 117 never names any equipment. Not one machine, not one brand, not one technology.

That is by design. Part 117 asks you to analyse your hazards and implement preventive controls where a hazard requires one. Whether a metal detector is the control, whether it is monitored, at what frequency, with what verification, and what records you keep — all of that flows out of your own hazard analysis. It does not flow out of a vendor's spec sheet. So when a salesperson tells you the regulation requires his machine, he is either mistaken or hoping you won't check. The regulation requires you to think; the machine is one possible answer to that thinking.

This has a useful implication when you buy: stop asking vendors "is it compliant?" and start asking "can it produce the evidence my hazard analysis says I need?" Those are very different questions, and the second one is answerable.

A Checklist You Can Run This Week

1. Pull the actual regulation text, not a summary. Confirm for yourself that the compliance date in the CFR reads 20 January 2026 and has not been amended.

2. Check the docket. Docket FDA-2014-N-0053, document 2025-14967. Confirm the extension is still a proposed rule with no final rule issued. Set a recurring reminder to re-check — the moment a final rule lands, your planning statement changes.

3. Have counsel read P.L. 119-37 directly. Confirm the enforcement-funding mechanism and the section reference from the enrolled text, since the section number is reported via a CRS report rather than read from the primary source.

4. Separate FDA enforcement risk from contractual risk. Search your customer agreements and retailer onboarding documents for traceability language. Those obligations do not care about FDA's appropriations.

5. Delete "FSMA 204" from your equipment specifications. It does not belong there. Replace it with what you actually need: hazard type, detection target, throughput, records retention, data output format.

6. Rebuild your equipment requirements from Part 117 instead. Start from the hazard analysis, decide the control, then specify the machine that can monitor, verify and record that control.

7. If net weight matters to you, open the correct file. FPLA, 21 CFR 101.7(q), NIST Handbook 133. Not FSMA. This is a different department of your compliance program and should have a different owner.

8. Track the lot-level flexibility discussion. Congress has directed quarterly FDA-industry engagement; the outcome may change your data model, which is far more expensive to retrofit than a machine.

9. Write your internal position in the precise language above. When an auditor or a buyer asks, the precise version protects you and the sloppy version does not.

Where Equipment Genuinely Helps — Stated Without Overclaiming

None of the above means inspection and weighing equipment is irrelevant. It means the justification has to be honest. If your hazard analysis identifies a physical-hazard control point, the machine is how you execute and evidence it. If your customer contract demands per-lot records, the machine's data output is how you produce them without a clipboard.

At MIQI we build to that logic rather than to a regulatory buzzword. The MQ-CW4523L3 checkweigher covers general in-line weight checking. The MQ-MCL4530L2 combines metal detection and checkweighing in one frame, which is what you want when floor space is tight and both a physical-hazard control and a weight check sit at the same station. The MQ-XR bagged-product X-ray inspection system addresses foreign objects that metal detection cannot reach — with the honest caveat that X-ray is a density-contrast technology and low-density objects remain a structural limitation of the physics, not a marketing problem to be waved away.

We are a source factory with nine product series and 44 models, and we support free sample testing and non-standard customization. We will also tell you plainly what we do not have: MIQI has not yet obtained CE or ISO 9001 certification, and we do not imply otherwise. We would rather you hear that from us than discover it during your vendor audit. And we will never put "FSMA 204 compliant" on a quotation, because no machine can be.

The Bottom Line

FSMA 204 was not delayed by FDA. FDA proposed a delay and has not finalized it. The 20 January 2026 date is still written in the regulation. The practical breathing room to 20 July 2028 comes from a congressional appropriations act operating as an enforcement funding prohibition, and appropriations mechanisms are periodic by nature. Meanwhile the rule itself is still moving, and it has never had anything to say about your equipment. Build your equipment case on 21 CFR Part 117 and your own hazard analysis. Build your traceability case on the actual record, not on a headline.

If you want to talk through which inspection or weighing configuration your hazard analysis actually justifies — including the cases where the answer is that you do not need to buy anything — reach us on WhatsApp at +1 (213) 563-6234 or by email at 897874196@qq.com. Ask for Engineer Cai. Send us your product and we will run a free sample test before you commit to anything.